Rights and permissions Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material
Benefits & Considerations Potential Benefits: Greater total fat loss Reduced hunger and cravings Possible metabolic improvements beyond semaglutide May help maintain results long-term Considerations: Not yet FDA-approved Side effects may overlap (nausea, constipation, fatigue) Long-term safety data still limited Why This Matters for the Future of Weight Management The combination of Retatrutide + Cagrilintide represents the next evolution of metabolic pharmacology, one that treats obesity like the complex, multi-hormonal disease it is
American Academy of Pediatrics Committee on Fetus and Newborn
Potent B12 fast delivery More energy, seems to help with food noise Quick service and has alc pafs abd bac water and syringes
Olanzapine, quetiapine, and risperidone cause weight gain of 10 to 30 pounds in many users through mechanisms involving histamine, serotonin, and dopamine receptor blockade
The clinical data suggesting a possible association come from post-marketing surveillance data that have substantial risk for bias and do not control for important confounding variables